Study #2016-0046
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This clinical trial studies eliminating surgery and how well radiation therapy after systemic therapy works in treating patients with HER2 positive or triple negative breast cancer when image-guided biopsy shows no residual cancer. Patients then receive standard breast radiotherapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Estrogen Receptor Negative;HER2 Positive Breast Carcinoma;HER2/Neu Negative;Invasive Breast Carcinoma;Progesterone Receptor Negative;Stage I Breast Cancer AJCC V7;Stage IA Breast Cancer AJCC V7;Stage IB Breast Cancer AJCC V7;Stage II Breast Cancer AJCC V6 and V7;Stage IIA Breast Cancer AJCC V6 and V7;Stage IIB Breast Cancer AJCC V6 and V7;Triple-Negative Breast Carcinoma
Study phase:
Not applicable
Physician name:
Henry Kuerer
Department:
Breast Surgical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.